As of 2:23pm ET
| -0.12 / -1.81%|
The 4 analysts offering 12-month price forecasts for Apollo Endosurgery Inc have a median target of 10.25, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a +57.69% increase from the last price of 6.50.
The current consensus among 4 polled investment analysts is to Buy stock in Apollo Endosurgery Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.